33 5 
Home Page  

  • SciELO

  • Google
  • SciELO
  • Google


Actas Urológicas Españolas

 ISSN 0210-4806

LLARENA IBARGUREN, Roberto. Treatment of metastatic renal cancer: current validity of immunotherapy. []. , 33, 5, pp.584-592. ISSN 0210-4806.

Objective:To assess the significance and effects of conventional immunotherapy for management of disseminated renal cancer. Materials and methods: Historical data from studies conducted with cytokines, interferon, and interleukin are reviewed, their combinations are evaluated, and the different relevant studies available are compared. Discussion: While diverse, results are poor in terms of objective response and its duration. Historical series using interleukin-2 achieved, despite severe side effects, disease remissions, some of them complete. Conclusions: Currently, after the advent of new drugs, use of conventional immunotherapy may be indicated for specific patients with a good general condition undergoing previous nephrectomy for a clear cell carcinoma at least 12 months before occurrence of metastasis in a single organ, preferably the lung, and with normal levels of hemoglobin, calcium, and lactate dehydrogenase, looking for that small percentage of stable and sustained responses.

: Immunotherapy; Cytokines; Interferon; Interleukin.

        · |     · |     · ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License